Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04874272 · ClinicalTrials.gov registry record · NA
Feasibility and Acceptability of a Chaplain-Led Post-Code Debrief Intervention
A NA study of Health Personnel Attitude, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 110
- Enrollment target
- 1
- Study location
NCT04874272: Completed NA study of Health Personnel Attitude, sponsored by Indiana University.
NCT04874272 is a NA study of Health Personnel Attitude that has completed, run by Indiana University. The registered enrollment target is 110 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04874272, a NA study of Health Personnel Attitude, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 110 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study is to increase the frequency and effectiveness of post code debriefs by piloting a novel intervention tool and partnering clinicians with board certified chaplains trained to facilitate group processes. A post code debrief will involve two aspects: a technical debrief (a discussion to process the technical, procedural aspects of a medical code/cardiopulmonary arrest), which will be led by a clinician, and an emotional debrief (a discussion to process the emotional, existential impact of a medical code/cardiopulmonary arrest), which will be led by a chaplain.
Primary Outcome
Participants complete surveys at 1 and 6 weeks post-CPA event
Conditions Studied
Interventions
- OTHER Chaplain led post-code debrief
Study Locations (1)
Indiana
- IU Health Methodist Hospital - Indianapolis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 110 participants |
| Start Date | 2020-11-06 |
| Est. Completion | 2022-08-12 |
| Phase | NA |
What the finished NCT04874272 record still lists
NCT04874272 is an interventional study that assigns participants to a tested intervention. The registered 110 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (92% lower).
The record links to 1 condition, with Health Personnel Attitude appearing as the primary indexed condition, and to 1 intervention - of which Chaplain led post-code debrief is the first listed.
NCT04874272 reports a single indexed study location in Indiana.
Frequently Asked Questions
What is clinical trial NCT04874272 about?
NCT04874272 is a clinical study titled "Feasibility and Acceptability of a Chaplain-Led Post-Code Debrief Intervention". The objective of this study is to increase the frequency and effectiveness of post code debriefs by piloting a novel intervention tool and partnering clinicians with board certified chaplains trained to facilitate group processes. A post code debrief will involve two aspects: a technical debrief (a ...
What is the current status of trial NCT04874272?
This trial is currently completed. It is a NA study. The enrollment target is 110 participants. The study started on 2020-11-06. Estimated completion is 2022-08-12.
What conditions does trial NCT04874272 study?
This clinical trial studies the following conditions: Health Personnel Attitude.
What interventions are being tested in trial NCT04874272?
The interventions under investigation include: Chaplain led post-code debrief (OTHER).
Who is sponsoring clinical trial NCT04874272?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04874272 being conducted?
This trial has 1 study location across Indiana. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04874272's enrollment target sits among peer trials
110 816th of 2000 higher than 1,176 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01530373 · 110 participants · Phase 2
Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer Patients
- NCT02379377 · 110 participants · Phase 1
18F-FSPG PET in Imaging Patients With Liver Cancer Before Undergoing Surgery or Transplant
- NCT02411773 · 110 participants · Phase 1
Sympatholysis in Chronic Kidney Disease
- NCT03190941 · 110 participants · Phase 1
Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing the G12V Variant of Mutated RAS in HLA-A*11:01 Patients
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI